salicylaldehyde isonicotinoyl hydrazone has been researched along with Chronic Illness in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adamcová, M; Čajnáková, H; Gersl, V; Hrbatová, L; Ponka, P; Popelová, O; Potáčová, A; Šimůnek, T; Sterba, M | 1 |
1 other study(ies) available for salicylaldehyde isonicotinoyl hydrazone and Chronic Illness
Article | Year |
---|---|
Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents.
Topics: Aldehydes; Animals; Cardiomyopathies; Cardiotonic Agents; Chronic Disease; Daunorubicin; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Heart Conduction System; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Pyridoxal; Rabbits; Razoxane; Time Factors; Troponin T | 2007 |